BUZZ-New Zealand's Pacific Edge surges on positive demand for its test

Reuters
2025/02/28
BUZZ-New Zealand's Pacific Edge surges on positive demand for its test

** Shares of Pacific Edge PEB.NZ rise 138% to NZ$0.15, their highest level since November 13, 2024

** Cancer diagnostics company announces that the American Urological Association has included its Cxbladder Triage as the standard of care for microhematuria

** Cxbladder Triage is a urine test designed to rule out cancer in patients with microhematuria (small amounts of blood in the urine that are not visible to the naked eye)

** Company expects a rise in demand for the tests as more clinicians incorporate the tests globally for the evaluation and management of patients

** Two million shares change hands, 2.6 times the 30-day average of 791,598 shares

(Reporting by Manasi Dasa in Bengaluru)

((Manasi.DasaSundeep@thomsonreuters.com;))

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10